MSMohammad Tariq Salman

Mohammad Tariq Salman

*This is an algorithmically generated author record based on publicly available information.

Mohammad Tariq Salman has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Assessment of medication errors and prescribing patterns in orthopaedic inpatients at a tertiary care hospital

    by M. Rehan, Mazhar Jamil, Mohd Asjad, Abdullah Khan, Mohd Aftab Siddiqui, Mohd Tariq Salman

    Background: The objectives of the study were to assess medication errors and prescribing patterns among orthopaedic inpatients at a tertiary care hospital and evaluate compliance with National Accreditation Board for Hospitals (NABH) medication safety standards across prescribing, transcribing, dispensing, and administration processes. Methods: A cross-sectional observational study was conducted over six months in the Orthopaedic Department of a tertiary care teaching hospital. A total of 110 case records were reviewed. Medication errors were identified using NABH standards, including prescription, transcription, dispensing, and administration errors. Errors were further classified based on severity using the NCC MERP index. Data were analyzed using appropriate statistical methods. Results: Among 21,312 medication-use opportunities evaluated, 750 medication errors were identified (overall error rate 3.52%). Prescription errors were most frequent (599;7.78%), followed by transcription (122;6.87%), dispensing (23;0.55%), and administration errors (6; 0.08%). Common prescribing errors included non-use of generic names (51.6%), omission of dosage (13.5%), and inappropriate capitalization (8.0%). Most errors were of minor to moderate severity and unlikely to cause direct patient harm. Antibiotics and non-steroidal anti-inflammatory drugs were the most commonly implicated drug classes. Conclusion: Medication errors were predominantly related to prescribing practices. Strengthening prescription protocols, encouraging generic prescribing, and implementing regular pharmacist-led audits can enhance medication safety and improve compliance with NABH standards.

  • Open Access

    Identification of radiation responsive proteins from Spleen and Intestine tissue of mice using Mass Spectrometry approach

    by Shabir Husain, Faisal Ahmed, Ram Kumar, Akhilesh K Saini, Smriti Shubham, Saggere M Shasthry, Mohammad Tariq Salman

    Purpose: Exposure to ionizing radiation (IR) can cause tissue damage, which is difficult to diagnose and treat as no biomarker is available for detection. We aimed to identify proteomic signature of radiation exposure (9.5Gry) in mice and to assess the utility of Podophyllotoxin extract (PTOX) in preventing radiation injury. Materials and Methods: Spleen and Small intestinal (SI) tissues were taken from control and lethally irradiated mice at different time intervals with or without pre-treatment with Podophyllotoxin extract. Proteins were identified using Mass Spectrometry and matched with Peptide Mass Fingerprinting. Results: We found multiple differentially expressed radiation responsive proteins from Spleen and SI tissues in irradiated mice at 24 hours and 30 days in comparison to healthy controls (pPodophyllotoxin treated group. Conclusions: Such proteins may be useful in early detection of radiation exposure. Pre-treatment with Podophyllotoxin leads to recovery of the disappeared proteins and improved survival following exposure to irradiation.

  • Open Access

    Neuroprotective effects of Nigella sativa extracts during germination on central nervous system

    by Iffat Zareen Ahmad, Mohammad Tariq Salman, Mohammad Hayatul Islam

    Background: Nigella sativa Linn. which has many acclaimed medicinal properties is an indigenous herbaceous plant and belongs to the Ranunculaceae family, which grows in countries bordering the Mediterranean Sea, Pakistan and India. Objective: This study was designed to investigate the effects of N. sativa seed extracts of different germination phases on the central nervous system (CNS) responses in experimental animals. Materials and Methods: Anxiolytic, locomotor activity of extracts (1 g/kg of body weight) was evaluated in both stressed and unstressed animal models and antiepileptic effect was evaluated by maximal electroshock seizure model keeping diazepam (20 mg/kg) as a positive control. Antidepressant effect was evaluated by forced swim test and tail suspension test keeping imipramine (15 mg/kg) as a positive control. Results: All tested extracts of N. sativa during different phases of germination (especially 5 th day germination phase) showed significant (P < 0.001) anxiolytic effect in comparison to control. Diazepam reduced locomotor activity in control (unstressed) rats but did not show affect in stressed rats while N. sativa extracts from germination phases significantly (P < 0.001) reduced locomotor activity in unstressed as well as stressed animals. All the extracts of N. sativa from different germination phases exhibited significant (P < 0.001) reduction in various phases of epileptic seizure on comparison with the reference standard (diazepam). During antidepressant test, N. sativa extracts exhibited a slight reduction in the immobility of rats. Conclusion: During germination, especially in 5 th day germination extract, N. sativa showed significant CNS depressant activity as compared to whole seeds that possibly may be due higher content of secondary metabolites produced during germination.


  • Protective Effects of Ethanolic Extract of Nigella sativa Seed in Paracetamol Induced Acute Hepatotoxicity In vivo

    by D.S. Kushwah, M.T. Salman, P. Singh, V.K. Verma, A. Ahmad

    Protective Effects of Ethanolic Extract of Nigella sativa Seed in Paracetamol Induced Acute Hepatotoxicity In vivo


  • In vivoHepatoprotective Potential ofNigella sativaExtract Against Rifampicin Induced Sub-chronic Hepatotoxicity and Altered Redox Status

    by Devendra Singh Kushwah, Mohd Tariq Salman, Hemant Kumar Singh, Ali Ahmad, V.K. Verma

    Despite the hepatotoxic effects of Rifampicin (RIF), its use is inevitable in the management of tuberculosis. No satisfactory treatment is available for prevention of this adverse effect. This study was undertaken to evaluate the protective effect of Nigella sativa extract (NSE) against Rifampicin induced sub-chronic hepatotoxicity. Male wistar rats were divided in 4 groups of 8 each and received vehicle, RIF (100 mg/ kg), RIF (100 mg/kg)+NSE (250 mg/kg) or RIF (100 mg/kg)+NSE (500 mg/kg) orally respectively for 28 days. Blood was withdrawn at day 14 and 28 for estimation of circulatory liver markers and anti-oxidant levels. At the end of the experiment histopathological study and estimation of SOD, CAT, GSH and LPO in liver samples was done. Pre-treatment of NSE produced significant hepatoprotection by decreasing the level of serum Alkaline phosphatase (ALP) (p<0.01), Serum glutamic pyruvic transaminase (SGPT) (p<0.001), Serum glutamic oxaloacetic transaminase (SGOT) (p<0.001), serum bilirubin (p<0.01), and liver MDA (p<0.05) levels by increasing the level of SOD (p<0.01), CAT (p<0.01), and GSH (p<0.001). Liver histopathology showed mononuclear infiltration, degenerative changes in hepatocytes, bridging necrosis extending from one portal tract to another along with portal triditis and microvesicular steatosis. Pre-treatment group of NSE (500 mg/kg) showed near normal liver architecture with microvesicular steatosis. Pre-treatment groups of NSE (250 mg/kg) showed near normal regaining of architecture of liver with persisting fatty degeneration in the portal tract. The results indicate that NSE possesses hepatoprotective action against RIF induced sub chronic hepatoxicity. Further research is needed to advocate its use in prevention of drug induced hepatotoxicity.


  • Open Access

    Effects of atorvastatin and rosuvastatin on high-sensitivity C-reactive protein and lipid profile in obese type 2 diabetes mellitus patients

    by Suyog Sindhu, Hemant Kumar Singh, Mohammad Tariq Salman, Jalees Fatima, Vinod Kumar Verma

    Objective: To evaluate and compare the effects on high-sensitivity C-reactive protein (hs-CRP) levels and lipid profile of atorvastatin and rosuvastatin in obese type 2 diabetes mellitus (T2DM) patients. Materials and Methods: A total of 40 subjects with 20 in each group were randomly allocated to two groups. Group 1 patients received atorvastatin and that of Group 2 rosuvastatin treatment for 6 months. The patients were administered atorvastatin (40-80 mg) and rosuvastatin(10-40 mg) in accordance to their LDL-C status as per NCEP-ATP III guidelines. The parameters studied were, hs-CRP and lipid profile comprising LDL-C, HDL-C, TG and TC. Results: Results obtained from the study, clearly indicate that atorvastatin (A) as well as rosuvastatin(R) have significant effect on lowering of hs-CRP levels (for A P=0.001; for R P=0.002), reducing LDL-C levels (for A P=0.008; for R P=0.001), elevating HDL-C levels (for A P=0.02; for R P=0.001) along with reducing TC (for A P=0.003; for R P=0.002) and TG (for A P=0.000; for R P=0.000) levels in obese T2DM patients. It is also seen that there is no significant (P>0.05) difference in effect of atorvastatin and rosuvastatin in lowering of hs-CRP levels, elevating HDL-C levels and reducing TG levels in obese T2DM patients. However, percentage lowering of LDL-C (P=0.000) and TC (P=0.001) by rosuvastatin is to a greater extent than that caused by atorvastatin in these patients. Conclusions: Thus this study throws light on the fact that rosuvastatin should be preferred over atorvastatin in obese T2DM patients in whom LDL-C and TC levels are deviated from normal reference values. In rest of obese T2DM either of atorvastatin or rosuvastatin can be employed to lower hs-CRP levels, to elevate HDL-C levels or to reduce TG levels.


  • Open Access

    Acceptability and safety profile of oral and sublingual misoprostol for uterine evacuation following early fetal demise

    by Devendra Singh Kushwah, Beenu Kushwah, Mohd Tariq Salman, V. K. Verma

    Background: It has been established that sublingual (SL) route of misoprostol has a great potential to be developed for medical abortion, but there is dearth of evidence to reveal satisfaction rate and safety profile among patients of oral and SL routes. Thus, this study was conducted to provide an insight into the acceptability and safety profile of the same. Materials and Methods: A randomized controlled trial was carried out by giving 200 mg mifepristone orally, followed by administration of 600 μ g misoprostol orally to 50 women and sublingually to 50 women. The primary endpoints of study were measurements of acceptability and safety profile parameters (average blood loss, nausea, vomiting, diarrhea, hot flushes, fever) of both the groups. The secondary endpoints of the study were number of doses required for complete abortion, success rate and the induction to evacuation interval in both the groups. Results: SL route of administration was more acceptable than the oral route ( P = 0.009). Average blood loss was higher in the oral group than in the SL group ( P = 0.001). Amongst the side effects, 34% in the SL group and 52% in the oral group had nausea ( P = 0.264), 22% in the SL group and 44% in the oral group had vomiting ( P = 0.031), 48% in the SL group and 86% in the oral group had diarrhea ( P < 0.05), hot flushes were presented by 24% in the SL group and 50% in the oral group ( P < 0.05), fever was presented by 20% in the SL group and 44% in the oral group ( P < 0.05), and the number of cases aborted with only one dose was higher (86%) in the SL group as compared to 63% in the oral group ( P = 0.004). The evacuation (success) rates were 92% in the SL group and 84% in the oral group ( P = 0.218) and the mean ± SD induction to evacuation intervals in the SL and oral groups were 5.6 ± 4.54 hours and 9.44 ± 5.61 hours, respectively ( P = 0.0002). Conclusion: The SL route had fewer undesirable effects, was more satisfactory, required less number of doses and was more acceptable to the patient compared to the oral route.


  • Open Access

    Bilateral acute angle closure glaucoma in a 50 year old female after oral administration of flavoxate

    by Zakir Shaik Mohammed, Zaka‐Ur‐Rab Simi, Salman Mohd Tariq, Khan Rahat Ali